(veracyte. Q1 2022 Business & Financial Presentation May 3, 2022 Disclaimer This presentation contains forward-looking statements, including, but not limited to, our statements related to our expected total revenue and other financial and operating results for 2022 and our plans, objectives, expectations (financial and otherwise) or intentions with respect to our Prosigna, Afirma, Percepta, Envisia, LymphMark, Decipher Prostate, Percepta Nasal Swab, Percepta Genomic Atlas and Decipher Bladder tests and prod ...

Veracyte, Inc. (NASDAQ:VCYT) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Marc Stapley – Chief Executive Officer Rebecca Chambers – Chief Financial Officer Giulia Kennedy – Chief Scientific & Medical Officer Tina Nova – General Manager of Thyroid & Urologic Cancer Sheila Goldman – Director of Investor Relations Conference Call Participants Brian Weinstein – William Blair David Hein – Goldman Sachs Mason Carrico – Stephens Inc. Tejas Savant – Morgan Stanley Paul Knight – KeyBa ...

veracyte. Q4 and Full Year 2021 Business & Financial Presentation February 28, 2022 Forward-Looking Statements This presentation contains forward-looking statements, including, but not limited to, our statements related to our expected total revenue and other financial and operating results for 2022 and our plans, objectives, expectations (financial and otherwise) or intentions with respect to our Prosigna, Afirma, Percepta, Envisia, LymphMark, Decipher Prostate, Percepta Nasal Swab, Percepta Genomic Atlas ...

Veracyte, Inc. (NASDAQ:VCYT) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Tracy Morris - VP of Corporate Communications & IR Marc Stapley - CEO Rebecca Chambers - CFO Tina Nova - General Manager of Thyroid & Urologic Cancer Giulia Kennedy - Chief Scientific & Medical Officer Conference Call Participants Brian Weinstein - William Blair Matt Sykes - Goldman Sachs Puneet Souda - SVB Leerink Mike Matson - Needham & Company Mason Carrico - Stephens Inc. Travis Broadhurst - L ...

veracyte. Third Quarter 2021 Performance Business & Financial Presentation November 9, 2021 Forward-Looking Statements This presentation contains statements that are not historical and that are based on our beliefs and assumptions and on information currently available to us. These statements constitute forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to known and unknown risks, uncerta ...

Call Start: 16:30 January 1, 0000 5:23 PM ET Veracyte, Inc. (NASDAQ:VCYT) Q3 2021 Earnings Conference Call November 9, 2021 16:30 ET Company Participants Tracy Morris - Vice President of Corporate Communications & Investor Relations Marc Stapley - Chief Executive Officer Rebecca Chambers - Chief Financial Officer Tina Nova - General Manager of Thyroid & Urologic Cancer Giulia Kennedy - Chief Scientific & Medical Officer Conference Call Participants Puneet Souda - SVB Leerink Matt Sykes - Goldman Sachs Mike ...

(veracyte. Second Quarter 2021 Performance July 29, 2021 Forward-Looking Statements This presentation contains statements that are not historical and that are based on our beliefs and assumptions and on information currently available to us. These statements constitute forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other fact ...

Veracyte, Inc. (NASDAQ:VCYT) Q2 2021 Earnings Conference Call July 29, 2021 4:30 PM ET Company Participants Tracy Morris - Vice President of Corporate Communications and Investor Relations Marc Stapley - Chief Executive Officer Rebecca Chambers - Chief Financial Officer Bonnie Anderson - Executive Chairwoman Conference Call Participants Brian Weinstein - William Blair Puneet Souda - SVB Leerink Sung Ji Nam - BTIG Dave Delahunt - Goldman Sachs Thomas Flaten - Lake Street Capital Tejas Savant - Morgan Stanley ...

Veracyte, Inc. (NASDAQ:VCYT) Q1 2021 Earnings Conference Call May 10, 2021 4:30 PM ET Company Participants Tracy Morris - Vice President, Corporate Communications and Investor Relations Bonnie Anderson - Chairman and Chief Executive Officer Jane Alley - Acting Chief Financial Officer Marc Stapley - Incoming Chief Executive Officer Giulia Kennedy - Chief Scientific and Medical Officer Tina Nova - General Manager, Thyroid & Urology Conference Call Participants Puneet Souda - SVB Leerink Brian Weinstein - Will ...

ANSWERSCorporate Presentation veracyte. April 5, 2021 Forward-Looking Statements This presentation contains statements that are not historical and that are based on our beliefs and assumptions and on information currently available to us. These statements constitute forward-looking statements within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other factors ...